Biblio

[ Author(Asc)] Title Type Year
Filters: Author is Wang, Meng  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wang M, Li Y, Xiao G-D, Zheng X-Q, Wang J-C, Xu C-W, Qin S, Ren H, Tang S-C, Sun X. H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells. Cell Prolif. 2018:e12534.
Wang M, Chen Y, Zhu M, Xu B, Guo W, Lyu Y, Zhang C. Pharmacological modulation of melanocortin-4 receptor by melanocortin receptor accessory protein 2 in Nile tilapia. Gen Comp Endocrinol. 2019:113219.
Wang M, Zhang J, Zhao H, Wan D, Jiang Z. Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models. Int Immunopharmacol. 2020;81:106205.
Wang M, Zhao H-Y, Zhang J-L, Wan D-M, Li Y-M, Jiang Z-X. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α. Exp Cell Res. 2020:112280.
Wang M, Dingler FA, Patel KJ. Genotoxic aldehydes in the hematopoietic system. Blood. 2022.
Wang M, Chen Z, Zhang Y. CBP/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos. EMBO J. 2022:e112012.
Wang M, Mequanint K. Preparation and Microscopic Mechanical Characterization of L-Methionine-Based Polyphosphazene Fibrous Mats for Vascular Tissue Engineering. Pharmaceutics. 2023;15(11).
Wang M, Wang X, Cui Y, Wen X. Impact of heterogeneous nuclear ribonucleoprotein A/B subtype overexpression on the expression of cancer stem cell markers CD133 and CD44 and cellular proliferation capacity. Cell Mol Biol (Noisy-le-grand). 2023;69(14):101-108.
Wang M, Li Q-J, Zhao H-Y, Zhang J-L. Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation. Hum Cell. 2024.